Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFEPIME vs CEFOXITIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFEPIME vs CEFOXITIN: Safety Overview

Metric CEFEPIME CEFOXITIN
Total FAERS Reports 5,540 750
Deaths Reported 997 48
Death Rate 18.0% 6.4%
Hospitalizations 3,055 252
Average Patient Age 56.5 yrs 50.8 yrs
% Female Patients 47.6% 57.6%
FDA Approval Date Aug 21, 2018 Approved Prior to Jan 1, 1982
Manufacturer Apotex Corp. B. Braun Medical Inc.
Route INTRAMUSCULAR INTRAVENOUS
Marketing Status Discontinued Discontinued